Search

Your search keyword '"Cohn, Betty"' showing total 8 results
Start Over Author "Cohn, Betty"
8 results on '"Cohn, Betty"'

7. Direct-to-consumer genetic testing in the news: a descriptive analysis

Author

Basch, Corey H., Hillyer, Grace C., Samuel, Lalitha, Datuowei, Erela, and Cohn, Betty

Subjects
Epidemiology, Research, Public Health, Environmental and Occupational Health, Genetics (clinical)
Abstract

Direct-to-consumer genetic testing (DTC GT) diagnostic tools do not entail referral through a healthcare provider and are used by consumers to screen for genetic health risk, pharmacogenomics, and predisposition to certain diseases and to learn more about ancestry. The purpose of this study was to describe the content of DTC DNA online news articles – specifically to characterize how rising concerns related to consumer privacy, medical advancements, and bioethics are covered in online news as access to these testing kits continues to grow. One hundred news articles identified on Google News using the search term “direct to consumer DNA testing” were coded for pre-determined content categories. Only 34.0% of news articles were created by healthcare professionals. Only 10.0% of online news articles mentioned testing confidentiality and privacy protection. Articles that mentioned > 5 commercial DTC DNA products more often discussed how DTC DNA testing provides personalized information about health and link to family disease risk and other traits (85.7% vs. 61.1%, p = 0.02), can lead to the location of family members or ancestors (78.6% vs. 55.63%, p = 0.03), and that the testing results housed in DNA databases can be utilized by law enforcement to track suspects or their relatives (32.1% vs. 9.7%, p = 0.01). Articles that mentioned ≤ 5 commercial DTC DNA products failed to mention that there exists a potential for data breaches (75.0% vs. 53.6%, p = 0.04). Online news articles should adequately inform consumers regarding the benefits and risks of DTC GT tests to facilitate informed decision-making.

Published
2022

8. Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges.

Author

Cohn, Betty, Ryan, Kerry A., Hendy, Katherine, Callahan, Katherine, Roberts, J. Scott, Spector‐Bagdady, Kayte, Mathews, Debra J. H., Blasco, Drew, Crumpler, Nicole, Feero, William Gregory, Ferber, Rebecca, Giri, Veda, Prince, Anya E. R., Sanghavi, Kunal, Uhlmann, Wendy, Vogle, Alyx, and Lee, Charles

Subjects
*HEALTH promotion, *YOUNG workers, *GENETIC testing
Abstract

Background: Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. Methods: Our landscaping review sought to discover the prevalence and distribution of wGT within voluntary wellness programs among U.S. companies using three approaches: (1) analysis of publicly available information; (2) national surveys; and (3) interviews with company representatives. Results: In total, 50/420 (11.9%) companies we investigated had publicly available data suggesting that they offer wGT to their employees. Survey data weighted to be representative of the type and distribution of U.S. companies suggest that ~1% of U.S. companies offer wGT to their employees. Conclusion: Our research found little evidence of broad uptake of wGT among U.S. companies, though information gathering was challenging. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results